PT Kalbe Farma Tbk. (PTKFY)

Market Cap	4.21B
Revenue (ttm)	2.00B
Net Income (ttm)	202.90M
Shares Out	n/a
EPS (ttm)	0.00
PE Ratio	20.75
Forward PE	18.71
Dividend	0.28 (1.45%)
Ex-Dividend Date	Jun 6, 2025

Volume	126
Average Volume	234
Open	19.50
Previous Close	19.50
Day's Range	19.50 - 19.50
52-Week Range	11.44 - 23.73
Beta	0.06
RSI	75.24
Earnings Date	Aug 1, 2025

About PT Kalbe Farma Tbk.

PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic divisions. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products. It operates Mitrasana Clinics, a health care service. In addition, the company pr...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1966
• Employees: 12,903
• Stock Exchange: OTCMKTS
• Ticker Symbol: PTKFY

Financial Performance

In 2024, PT Kalbe Farma Tbk.'s revenue was 32.63 trillion, an increase of 7.16% compared to the previous year's 30.45 trillion. Earnings were 3.24 trillion, an increase of 17.13%.

Financial numbers in IDR